// App-Quantinova.ai

119 : On-trial radiotherapy quality assurance in NeoSCOPE: A randomised phase II trial of chemoradiotherapy in oesophageal cancer.

Researchers

Presenter

  • Elin Evans

Principal Investigators

  • Gareth Jones

  • Ganesh Radhakrishna

  • Maria A Hawkins

  • Somnath Mukherjee

  • Rhydian Maggs

  • Ruby Ray

  • Tom David Lewis Crosby

  • Sarah Gwynne

Medical Centers

  • Velindre Cancer Centre, Cardiff, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Cardiff NCRI RTTQA Group, Cardiff, United Kingdom

  • Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom

  • Singleton Hospital, Swansea, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Prospective

Phase

  • II

Study Id's

  • NCT01843829

Sponsors

  • N/A

Result

  • N/A